FRESH
Research type
Research Study
Full title
Evaluation of fluid volume in patients with sepsis and refractory hypotension
IRAS ID
216185
Contact name
Lui Forni
Contact email
Sponsor organisation
Cheetah Medical Inc
Clinicaltrials.gov Identifier
Duration of Study in the UK
1 years, 0 months, 31 days
Research summary
The Cheetah Medical Starling SV device (‘the device’) is being tested as a novel treatment for patients with sepsis and refractory hypotension. This study will determine if assessing fluid responsiveness with the device can lead to less IV fluid being given and improve the outcome of patients with sepsis, compared with the usual standard of care. The ability to measure the heart function before giving IV fluid has proved to have good patient benefit, this study will support this practice.
REC name
London - South East Research Ethics Committee
REC reference
16/LO/2147
Date of REC Opinion
21 Feb 2017
REC opinion
Further Information Favourable Opinion